May 16 (Reuters) - British drugmaker GSK said on Thursday it plans to sell about 385 million shares, representing its entire shareholding, in spun-off consumer healthcare business Haleon. (Reporting by Anchal Rana in Bengaluru; Editing by Shilpi Majumdar)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,626 GBX | -0.15% | +1.55% | +11.90% |
12:30pm | Moderna COVID/flu combo vaccine superior to separate shots in trial | RE |
10:04am | Investors remain cautious as political instability takes over Europe |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,626 GBX | -0.15% | +1.55% | 84.52B | ||
325.2 GBX | -1.56% | -0.52% | 38.38B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.90% | 84.52B | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.87% | 248B | |
-1.72% | 219B | |
+11.08% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GSK intends to sell its entire stake in Haleon